Global Nuclear Medicine Radioisotope Industry

Global Nuclear Medicine Radioisotope Market to Reach US$36. 9 Billion by the Year 2027. Amid the COVID-19 crisis, the global market for Nuclear Medicine Radioisotope estimated at US$17. 1 Billion in the year 2020, is projected to reach a revised size of US$36.

New York, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Nuclear Medicine Radioisotope Industry" - https://www.reportlinker.com/p05957532/?utm_source=GNW
9 Billion by 2027, growing at a CAGR of 11.6% over the analysis period 2020-2027.Technetium-99m (Tc-99m), one of the segments analyzed in the report, is projected to grow at a 12.3% CAGR to reach US$24.8 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Thallium-201 (Tl-201) segment is readjusted to a revised 10.6% CAGR for the next 7-year period. This segment currently accounts for a 10.4% share of the global Nuclear Medicine Radioisotope market.

The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 11.1% CAGR for the Period of 2020-2027

The Nuclear Medicine Radioisotope market in the U.S. is estimated at US$5.1 Billion in the year 2020. The country currently accounts for a 29.51% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$6.4 Billion in the year 2027 trailing a CAGR of 11.1% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.3% and 9.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR while Rest of European market (as defined in the study) will reach US$6.4 Billion by the year 2027.

Iodine (I-123) Segment Corners a 8.6% Share in 2020

In the global Iodine (I-123) segment, USA, Canada, Japan, China and Europe will drive the 11.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.2 Billion in the year 2020 will reach a projected size of US$2.5 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.3 Billion by the year 2027.We bring years of research experience to this 9th edition of our report. The 192-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

• Bayer Healthcare AG

• Bracco Imaging SpA

• Cardinal Health, Inc.

• GE Healthcare

• Hologic, Inc.

• Lantheus Medical Imaging, Inc.

• Medtronic PLC

• NTP Radioisotopes SOC Ltd.

• Positron Corporation

• Siemens Healthineers

Read the full report: https://www.reportlinker.com/p05957532/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Nuclear Medicine Radioisotope Competitor Market Share Scenario
Worldwide (in %): 2018E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Nuclear Medicine
Radioisotope by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2018 through
2027

Table 2: World Historic Review for Nuclear Medicine
Radioisotope by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 3: World 15-Year Perspective for Nuclear Medicine
Radioisotope by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World Markets for Years 2012, 2018 & 2027

Table 4: World Current & Future Analysis for Technetium-99m
(Tc-99m) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2018 through
2027

Table 5: World Historic Review for Technetium-99m (Tc-99m) by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 6: World 15-Year Perspective for Technetium-99m (Tc-99m)
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 7: World Current & Future Analysis for Thallium-201
(Tl-201) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2018 through
2027

Table 8: World Historic Review for Thallium-201 (Tl-201) by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 9: World 15-Year Perspective for Thallium-201 (Tl-201) by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 10: World Current & Future Analysis for Iodine (I-123) by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 11: World Historic Review for Iodine (I-123) by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 12: World 15-Year Perspective for Iodine (I-123) by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 13: World Current & Future Analysis for Gallium-67
(Ga-67) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2018 through
2027

Table 14: World Historic Review for Gallium-67 (Ga-67) by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 15: World 15-Year Perspective for Gallium-67 (Ga-67) by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 16: World Current & Future Analysis for Other Type of
Radioisotopes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2018 through
2027

Table 17: World Historic Review for Other Type of Radioisotopes
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 18: World 15-Year Perspective for Other Type of
Radioisotopes by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2012, 2018 & 2027

Table 19: World Current & Future Analysis for Oncology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 20: World Historic Review for Oncology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 21: World 15-Year Perspective for Oncology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 22: World Current & Future Analysis for Cardiology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 23: World Historic Review for Cardiology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 24: World 15-Year Perspective for Cardiology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

Table 25: World Current & Future Analysis for Lymphoma by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 26: World Historic Review for Lymphoma by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 27: World 15-Year Perspective for Lymphoma by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 28: World Current & Future Analysis for Thyroid by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 29: World Historic Review for Thyroid by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 30: World 15-Year Perspective for Thyroid by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 31: World Current & Future Analysis for Neurology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027

Table 32: World Historic Review for Neurology by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 33: World 15-Year Perspective for Neurology by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027

Table 34: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2018 through
2027

Table 35: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 36: World 15-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Nuclear Medicine Radioisotope Market Share (in %) by
Company: 2018 & 2027
Market Analytics
Table 37: USA Current & Future Analysis for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes - Independent Analysis of Annual
Sales in US$ Billion for the Years 2018 through 2027

Table 38: USA Historic Review for Nuclear Medicine Radioisotope
by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201
(Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of
Radioisotopes Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 39: USA 15-Year Perspective for Nuclear Medicine
Radioisotope by Type of Radioisotope - Percentage Breakdown of
Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201),
Iodine (I-123), Gallium-67 (Ga-67) and Other Type of
Radioisotopes for the Years 2012, 2018 & 2027

Table 40: USA Current & Future Analysis for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications - Independent
Analysis of Annual Sales in US$ Billion for the Years 2018
through 2027

Table 41: USA Historic Review for Nuclear Medicine Radioisotope
by Application - Oncology, Cardiology, Lymphoma, Thyroid,
Neurology and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 42: USA 15-Year Perspective for Nuclear Medicine
Radioisotope by Application - Percentage Breakdown of Value
Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology
and Other Applications for the Years 2012, 2018 & 2027

CANADA
Table 43: Canada Current & Future Analysis for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes - Independent Analysis of Annual
Sales in US$ Billion for the Years 2018 through 2027

Table 44: Canada Historic Review for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2017

Table 45: Canada 15-Year Perspective for Nuclear Medicine
Radioisotope by Type of Radioisotope - Percentage Breakdown of
Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201),
Iodine (I-123), Gallium-67 (Ga-67) and Other Type of
Radioisotopes for the Years 2012, 2018 & 2027

Table 46: Canada Current & Future Analysis for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications - Independent
Analysis of Annual Sales in US$ Billion for the Years 2018
through 2027

Table 47: Canada Historic Review for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 48: Canada 15-Year Perspective for Nuclear Medicine
Radioisotope by Application - Percentage Breakdown of Value
Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology
and Other Applications for the Years 2012, 2018 & 2027

JAPAN
Table 49: Japan Current & Future Analysis for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes - Independent Analysis of Annual
Sales in US$ Billion for the Years 2018 through 2027

Table 50: Japan Historic Review for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2017

Table 51: Japan 15-Year Perspective for Nuclear Medicine
Radioisotope by Type of Radioisotope - Percentage Breakdown of
Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201),
Iodine (I-123), Gallium-67 (Ga-67) and Other Type of
Radioisotopes for the Years 2012, 2018 & 2027

Table 52: Japan Current & Future Analysis for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications - Independent
Analysis of Annual Sales in US$ Billion for the Years 2018
through 2027

Table 53: Japan Historic Review for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 54: Japan 15-Year Perspective for Nuclear Medicine
Radioisotope by Application - Percentage Breakdown of Value
Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology
and Other Applications for the Years 2012, 2018 & 2027

CHINA
Table 55: China Current & Future Analysis for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes - Independent Analysis of Annual
Sales in US$ Billion for the Years 2018 through 2027

Table 56: China Historic Review for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2017

Table 57: China 15-Year Perspective for Nuclear Medicine
Radioisotope by Type of Radioisotope - Percentage Breakdown of
Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201),
Iodine (I-123), Gallium-67 (Ga-67) and Other Type of
Radioisotopes for the Years 2012, 2018 & 2027

Table 58: China Current & Future Analysis for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications - Independent
Analysis of Annual Sales in US$ Billion for the Years 2018
through 2027

Table 59: China Historic Review for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 60: China 15-Year Perspective for Nuclear Medicine
Radioisotope by Application - Percentage Breakdown of Value
Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology
and Other Applications for the Years 2012, 2018 & 2027

EUROPE
Market Facts & Figures
European Nuclear Medicine Radioisotope Market: Competitor
Market Share Scenario (in %) for 2018 & 2027
Market Analytics
Table 61: Europe Current & Future Analysis for Nuclear Medicine
Radioisotope by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2018 through 2027

Table 62: Europe Historic Review for Nuclear Medicine
Radioisotope by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Billion for Years 2012 through 2017

Table 63: Europe 15-Year Perspective for Nuclear Medicine
Radioisotope by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK and Rest of Europe
Markets for Years 2012, 2018 & 2027

Table 64: Europe Current & Future Analysis for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes - Independent Analysis of Annual
Sales in US$ Billion for the Years 2018 through 2027

Table 65: Europe Historic Review for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2017

Table 66: Europe 15-Year Perspective for Nuclear Medicine
Radioisotope by Type of Radioisotope - Percentage Breakdown of
Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201),
Iodine (I-123), Gallium-67 (Ga-67) and Other Type of
Radioisotopes for the Years 2012, 2018 & 2027

Table 67: Europe Current & Future Analysis for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications - Independent
Analysis of Annual Sales in US$ Billion for the Years 2018
through 2027

Table 68: Europe Historic Review for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 69: Europe 15-Year Perspective for Nuclear Medicine
Radioisotope by Application - Percentage Breakdown of Value
Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology
and Other Applications for the Years 2012, 2018 & 2027

FRANCE
Table 70: France Current & Future Analysis for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes - Independent Analysis of Annual
Sales in US$ Billion for the Years 2018 through 2027

Table 71: France Historic Review for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2017

Table 72: France 15-Year Perspective for Nuclear Medicine
Radioisotope by Type of Radioisotope - Percentage Breakdown of
Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201),
Iodine (I-123), Gallium-67 (Ga-67) and Other Type of
Radioisotopes for the Years 2012, 2018 & 2027

Table 73: France Current & Future Analysis for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications - Independent
Analysis of Annual Sales in US$ Billion for the Years 2018
through 2027

Table 74: France Historic Review for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 75: France 15-Year Perspective for Nuclear Medicine
Radioisotope by Application - Percentage Breakdown of Value
Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology
and Other Applications for the Years 2012, 2018 & 2027

GERMANY
Table 76: Germany Current & Future Analysis for Nuclear
Medicine Radioisotope by Type of Radioisotope - Technetium-99m
(Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67
(Ga-67) and Other Type of Radioisotopes - Independent Analysis
of Annual Sales in US$ Billion for the Years 2018 through 2027

Table 77: Germany Historic Review for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2017

Table 78: Germany 15-Year Perspective for Nuclear Medicine
Radioisotope by Type of Radioisotope - Percentage Breakdown of
Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201),
Iodine (I-123), Gallium-67 (Ga-67) and Other Type of
Radioisotopes for the Years 2012, 2018 & 2027

Table 79: Germany Current & Future Analysis for Nuclear
Medicine Radioisotope by Application - Oncology, Cardiology,
Lymphoma, Thyroid, Neurology and Other Applications -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027

Table 80: Germany Historic Review for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 81: Germany 15-Year Perspective for Nuclear Medicine
Radioisotope by Application - Percentage Breakdown of Value
Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology
and Other Applications for the Years 2012, 2018 & 2027

ITALY
Table 82: Italy Current & Future Analysis for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes - Independent Analysis of Annual
Sales in US$ Billion for the Years 2018 through 2027

Table 83: Italy Historic Review for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2017

Table 84: Italy 15-Year Perspective for Nuclear Medicine
Radioisotope by Type of Radioisotope - Percentage Breakdown of
Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201),
Iodine (I-123), Gallium-67 (Ga-67) and Other Type of
Radioisotopes for the Years 2012, 2018 & 2027

Table 85: Italy Current & Future Analysis for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications - Independent
Analysis of Annual Sales in US$ Billion for the Years 2018
through 2027

Table 86: Italy Historic Review for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 87: Italy 15-Year Perspective for Nuclear Medicine
Radioisotope by Application - Percentage Breakdown of Value
Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology
and Other Applications for the Years 2012, 2018 & 2027

UNITED KINGDOM
Table 88: UK Current & Future Analysis for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes - Independent Analysis of Annual
Sales in US$ Billion for the Years 2018 through 2027

Table 89: UK Historic Review for Nuclear Medicine Radioisotope
by Type of Radioisotope - Technetium-99m (Tc-99m), Thallium-201
(Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and Other Type of
Radioisotopes Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017

Table 90: UK 15-Year Perspective for Nuclear Medicine
Radioisotope by Type of Radioisotope - Percentage Breakdown of
Value Sales for Technetium-99m (Tc-99m), Thallium-201 (Tl-201),
Iodine (I-123), Gallium-67 (Ga-67) and Other Type of
Radioisotopes for the Years 2012, 2018 & 2027

Table 91: UK Current & Future Analysis for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications - Independent
Analysis of Annual Sales in US$ Billion for the Years 2018
through 2027

Table 92: UK Historic Review for Nuclear Medicine Radioisotope
by Application - Oncology, Cardiology, Lymphoma, Thyroid,
Neurology and Other Applications Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017

Table 93: UK 15-Year Perspective for Nuclear Medicine
Radioisotope by Application - Percentage Breakdown of Value
Sales for Oncology, Cardiology, Lymphoma, Thyroid, Neurology
and Other Applications for the Years 2012, 2018 & 2027

REST OF EUROPE
Table 94: Rest of Europe Current & Future Analysis for Nuclear
Medicine Radioisotope by Type of Radioisotope - Technetium-99m
(Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67
(Ga-67) and Other Type of Radioisotopes - Independent Analysis
of Annual Sales in US$ Billion for the Years 2018 through 2027

Table 95: Rest of Europe Historic Review for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2017

Table 96: Rest of Europe 15-Year Perspective for Nuclear
Medicine Radioisotope by Type of Radioisotope - Percentage
Breakdown of Value Sales for Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes for the Years 2012, 2018 & 2027

Table 97: Rest of Europe Current & Future Analysis for Nuclear
Medicine Radioisotope by Application - Oncology, Cardiology,
Lymphoma, Thyroid, Neurology and Other Applications -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027

Table 98: Rest of Europe Historic Review for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 99: Rest of Europe 15-Year Perspective for Nuclear
Medicine Radioisotope by Application - Percentage Breakdown of
Value Sales for Oncology, Cardiology, Lymphoma, Thyroid,
Neurology and Other Applications for the Years 2012, 2018 &
2027

ASIA-PACIFIC
Table 100: Asia-Pacific Current & Future Analysis for Nuclear
Medicine Radioisotope by Type of Radioisotope - Technetium-99m
(Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67
(Ga-67) and Other Type of Radioisotopes - Independent Analysis
of Annual Sales in US$ Billion for the Years 2018 through 2027

Table 101: Asia-Pacific Historic Review for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2017

Table 102: Asia-Pacific 15-Year Perspective for Nuclear
Medicine Radioisotope by Type of Radioisotope - Percentage
Breakdown of Value Sales for Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes for the Years 2012, 2018 & 2027

Table 103: Asia-Pacific Current & Future Analysis for Nuclear
Medicine Radioisotope by Application - Oncology, Cardiology,
Lymphoma, Thyroid, Neurology and Other Applications -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027

Table 104: Asia-Pacific Historic Review for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 105: Asia-Pacific 15-Year Perspective for Nuclear
Medicine Radioisotope by Application - Percentage Breakdown of
Value Sales for Oncology, Cardiology, Lymphoma, Thyroid,
Neurology and Other Applications for the Years 2012, 2018 &
2027

REST OF WORLD
Table 106: Rest of World Current & Future Analysis for Nuclear
Medicine Radioisotope by Type of Radioisotope - Technetium-99m
(Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Gallium-67
(Ga-67) and Other Type of Radioisotopes - Independent Analysis
of Annual Sales in US$ Billion for the Years 2018 through 2027

Table 107: Rest of World Historic Review for Nuclear Medicine
Radioisotope by Type of Radioisotope - Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes Markets - Independent Analysis of
Annual Sales in US$ Billion for Years 2012 through 2017

Table 108: Rest of World 15-Year Perspective for Nuclear
Medicine Radioisotope by Type of Radioisotope - Percentage
Breakdown of Value Sales for Technetium-99m (Tc-99m),
Thallium-201 (Tl-201), Iodine (I-123), Gallium-67 (Ga-67) and
Other Type of Radioisotopes for the Years 2012, 2018 & 2027

Table 109: Rest of World Current & Future Analysis for Nuclear
Medicine Radioisotope by Application - Oncology, Cardiology,
Lymphoma, Thyroid, Neurology and Other Applications -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027

Table 110: Rest of World Historic Review for Nuclear Medicine
Radioisotope by Application - Oncology, Cardiology, Lymphoma,
Thyroid, Neurology and Other Applications Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017

Table 111: Rest of World 15-Year Perspective for Nuclear
Medicine Radioisotope by Application - Percentage Breakdown of
Value Sales for Oncology, Cardiology, Lymphoma, Thyroid,
Neurology and Other Applications for the Years 2012, 2018 &
2027

IV. COMPETITION
Total Companies Profiled: 55
Read the full report: https://www.reportlinker.com/p05957532/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001